Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Bullboard Posts
Post by desolationsoundon Dec 29, 2014 4:09pm
215 Views
Post# 23270128

Game Changer - getting rid of auditor's notes in Financials

Game Changer - getting rid of auditor's notes in FinancialsIn MHO.....
Always read auditor's notes in any company financial statements.  Quotes from  the Microbix news release today:

"improvements in the Company's earnings, liquidity and overall financial position during the year ended September 30, 2014, and projected improvements on a go-forward basis, resulted in the Company's independent public accounting firm removing a longstanding cautionary note from its audit report dated December 19, 2014. In previous years, this note expressed uncertainty about the Company's ability to continue as a going concern; also known as a "going concern" notice.

I think the removal of these auditor cautionary notes  could really open up opportunities for some insititutional investors to start taking positions in Microbix.  ( as I think that any "going concern notices/references"  could make some of these folks  think twice about making an investement)  For retail investors this is very good news as it will help to increase demand for the stock  as more institutional investors start buying the stock and thus  MBX SP increases  !!!
Bullboard Posts